Toggle Main Menu Toggle Search

Open Access padlockePrints

A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening

Lookup NU author(s): Dr Richard Gallon, Rachel Phelps, Christine Hayes, Sarah Mills, Dr Gillian Borthwick, Dr Mauro Santibanez Koref, Dr Ciaron McAnulty, Dr Michael Jackson

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Background: Lynch syndrome (LS) is under-diagnosed. UK National Institute for Health and Care Excellence guidelines recommend multistep molecular testing of all colorectal cancers (CRCs) to screen for LS. However, the complexity of the pathway has resulted in limited improvement in diagnosis.Methods: One-step multiplex PCR was used to generate sequencing-ready amplicons from 14 microsatellite instability (MSI) markers and 22 BRAF, KRAS, and NRAS mutation hotspots. MSI and BRAF/RAS variants were detected using amplicon-sequencing and automated analysis. The assay was clinically validated and deployed into service in northern England, followed by regional and local audits to assess its impact.Results: MSI analysis achieved 99.1% sensitivity and 99.2% specificity and was reproducible (r = 0.995). Mutation hotspot analysis had 100% sensitivity, 99.9% specificity, and was reproducible (r = 0.998). Assay-use in service in 2022-2023 increased CRC testing (97.2% (2466/2536) versus 28.6% (601/2104)), halved turnaround times, and identified more CRC patients at-risk of LS (5.5% (139/2536) versus 2.9% (61/2104)) compared to 2019-2020 when a multi-test pathway was used.Conclusion: A novel amplicon-sequencing assay of CRCs, including all biomarkers for LS screening and anti-EGFR therapy, achieved >95% testing rate. Adoption of this low cost, scalable, and fully automatable test will complement on-going, national initiatives to improve LS screening.


Publication metadata

Author(s): Gallon R, Herrero-Belmonte P, Phelps R, Hayes C, Sollars E, Egan D, Spiewak H, Nalty S, Mills S, Loo P-S, Borthwick G, Santibanez-Koref M, Burn J, McAnulty C, Jackson MS

Publication type: Article

Publication status: Published

Journal: BJC reports

Year: 2024

Volume: 2

Issue: 1

Online publication date: 01/07/2024

Acceptance date: 09/06/2024

Date deposited: 20/11/2024

ISSN (electronic): 2731-9377

Publisher: Nature

URL: https://doi.org/10.1038/s44276-024-00072-8

DOI: 10.1038/s44276-024-00072-8

Data Access Statement: Amplicon sequence FASTQ files are available from the European Nucleotide Archive (https://www.ebi.ac.uk/ena/browser/home) using study ID PRJEB67820. R (version 4.2.2) code for simulation analyses is available on request from the corresponding author.

PubMed id: 38962168


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
Cancer Research UK and the AsCaP group (C569/A24991)
The Barbour Foundation (UK charity 328081)

Share